If you invest in the stock market, you must know the Johnson Pharmacare share price targets for 2026, 2027, 2028, 2029, 2030, 2040, and 2050. Here, you will get detailed information regarding all your queries, such as its fundamentals, shareholdings, financial performance, future predictions, and more.
Table of Contents
About Johnson Pharmacare Ltd.
Johnson Pharmacare is an emerging Indian pharmaceutical company focused on manufacturing affordable medicines and healthcare products. The company operates in the fields of generic drugs, tablets, and healthcare solutions that cater to daily medical requirements. Its objective is to provide safe, high-quality, and low-cost medicines to people across the country. Johnson Pharmacare is attracting the attention of investors seeking pharmaceutical stocks, healthcare investments, and long-term growth opportunities within the Indian pharma sector. Given the rising demand for healthcare and medicines, the company holds strong prospects within the rapidly expanding pharmaceutical market.
Fundamental Analysis of Johnson Pharmacare
- Market Cap: ₹33.0 Cr.
- High / Low: ₹0.97 / ₹0.47
- Stock P/E: —
- Book Value: ₹1.02
- Dividend Yield: 0.00%
- ROCE: -0.43%
- ROE: -0.44%
- Face Value: ₹1
Johnson Pharmacare Share Price Target 2026
After analysing past price trends and market performance, it is estimated that the Johnson Pharmacare stock price could reach a minimum of ₹0.3 and potentially achieve a maximum target of ₹0.7 in the year 2026.
Johnson Pharmacare Share Price Target 2027
After analysing past price trends and market performance, it is estimated that the Johnson Pharmacare stock price could reach a minimum of ₹0.4 and potentially achieve a maximum target of ₹0.8 in the year 2027.
Johnson Pharmacare Share Price Target 2028
After analysing past price trends and market performance, it is estimated that the Johnson Pharmacare stock price could reach a minimum of ₹0.6 and potentially achieve a maximum target of ₹1 in the year 2028.
Johnson Pharmacare Share Price Target 2029
After analysing past price trends and market performance, it is estimated that the Johnson Pharmacare stock price could reach a minimum of ₹1 and potentially achieve a maximum target of ₹5 in the year 2029.
Johnson Pharmacare Share Price Target 2030
After analysing past price trends and market performance, it is estimated that the Johnson Pharmacare stock price could reach a minimum of ₹5 and potentially achieve a maximum target of ₹10 in the year 2030.
Johnson Pharmacare Share Price Target 2040
After analysing past price trends and market performance, it is estimated that the Johnson Pharmacare stock price could reach a minimum of ₹20 and potentially achieve a maximum target of ₹40 in the year 2040.
Johnson Pharmacare Share Price Target 2050
After analysing past price trends and market performance, it is estimated that the Johnson Pharmacare stock price could reach a minimum of ₹80 and potentially achieve a maximum target of ₹100 in the year 2050.
Shareholding Pattern of Johnson Pharmacare
- Retail and Others: 100%
Retail & Others: 100%Should You Invest in Johnson Pharmacare Stock?
| Year | Target Price (₹) |
|---|---|
| 2026 | 0.3–0.7 |
| 2027 | 0.4–0.8 |
| 2028 | 0.6–1 |
| 2029 | 1–5 |
| 2030 | 5–10 |
| 2040 | 20–40 |
| 2050 | 80–100 |
Whether you should invest or not, it depends on the many factors. Let us know the risk and opportunities to invest in Johnson Pharmacare stock.
Opportunities
- The growing demand for affordable medicines in India creates strong potential for revenue growth and offers immense opportunities for investment in pharmaceutical stocks.
- A focus on generic drugs improves profit margins and attracts investors interested in companies providing low-cost healthcare solutions.
- The expansion of the healthcare sector and increasing medical requirements generate long-term growth opportunities for pharmaceutical stocks.
- The ability to launch new drugs and products can increase market share and bolster investor confidence.
- Strong demand within the domestic market drives stable earnings and business growth.
Risks
- Strict government regulations and delays in drug approvals may lead to delays in product launches and impact revenue growth.
- Intense competition from larger pharmaceutical companies could erode pricing power and reduce profit margins.
- Dependence on raw material supplies may impact production levels and overall business performance.
- Changes in pharmaceutical pricing policies could have an adverse effect on earnings and stock market performance.
- The risk of product failure or regulatory issues could undermine investor confidence and growth potential.
Key Competitors of Johnson Pharmacare
Key competitors or peer companies of Johnson Pharmacare are Sun Pharmaceutical Industries, Dr. Reddy’s Laboratories, Cipla, Lupin, Aurobindo Pharma, Zydus Lifesciences, Torrent Pharmaceuticals, Alkem Laboratories, Biocon, and Glenmark Pharmaceuticals.
Disclaimer: All the information provided in this article is for educational purposes only. DateUpdateGo always advises seeking guidance from a certified financial advisor before making any investment-related decisions.
